Elena Toschi1,2, Astrid Atakov-Castillo1, Christine Slyne1, Medha Munshi1,2,3. 1. Joslin Diabetes Center, Boston, Massachusetts, USA. 2. Harvard Medical School, Boston, Massachusetts, USA. 3. Beth Israel Deaconess Medical Center Boston, Massachusetts, USA.
Abstract
Objective: To assess the impact of initiation of closed-loop control (CLC) on glycemic metrics in older adults with type 1 diabetes (T1D) in the real world. Methods: Retrospective analysis of electronic health records from a single tertiary diabetes center of older adults prescribed CLC between January and December 2020. Results: Forty-eight patients (mean age 70 ± 4 years, T1D duration 42 ± 14 years) were prescribed CLC and 39/48 started on the CLC. Among the CLC starters, 97.5% and 95% were prior pump and continuous glucose monitoring (CGM) users, respectively. CGM metrics showed an increase in time-in-range (62% ± 13% to 76% ± 9%; P < 0.001), a reduction in both time spent <70 mg/dL [2% (1%-3%) to 1% (1%-2%); P = 0.03] and >180 mg/dL (30% ± 11% to 20% ± 9%; P < 0.001) at 3 months. Conclusion: In this real-world data most of the older patients with T1D initiating CLC were prior pump and CGM users. Initiation of CLC improved glycemic control and reduced time spent in hypoglycemia compared with prior therapy.
Objective: To assess the impact of initiation of closed-loop control (CLC) on glycemic metrics in older adults with type 1 diabetes (T1D) in the real world. Methods: Retrospective analysis of electronic health records from a single tertiary diabetes center of older adults prescribed CLC between January and December 2020. Results: Forty-eight patients (mean age 70 ± 4 years, T1D duration 42 ± 14 years) were prescribed CLC and 39/48 started on the CLC. Among the CLC starters, 97.5% and 95% were prior pump and continuous glucose monitoring (CGM) users, respectively. CGM metrics showed an increase in time-in-range (62% ± 13% to 76% ± 9%; P < 0.001), a reduction in both time spent <70 mg/dL [2% (1%-3%) to 1% (1%-2%); P = 0.03] and >180 mg/dL (30% ± 11% to 20% ± 9%; P < 0.001) at 3 months. Conclusion: In this real-world data most of the older patients with T1D initiating CLC were prior pump and CGM users. Initiation of CLC improved glycemic control and reduced time spent in hypoglycemia compared with prior therapy.
Authors: Sue A Brown; Boris P Kovatchev; Dan Raghinaru; John W Lum; Bruce A Buckingham; Yogish C Kudva; Lori M Laffel; Carol J Levy; Jordan E Pinsker; R Paul Wadwa; Eyal Dassau; Francis J Doyle; Stacey M Anderson; Mei Mei Church; Vikash Dadlani; Laya Ekhlaspour; Gregory P Forlenza; Elvira Isganaitis; David W Lam; Craig Kollman; Roy W Beck Journal: N Engl J Med Date: 2019-10-16 Impact factor: 91.245
Authors: Augustina M A Brands; Geert Jan Biessels; Edward H F de Haan; L Jaap Kappelle; Roy P C Kessels Journal: Diabetes Care Date: 2005-03 Impact factor: 19.112
Authors: Alessandro Bisio; Linda Gonder-Frederick; Ryan McFadden; Daniel Cherñavvsky; Mary Voelmle; Michael Pajewski; Pearl Yu; Heather Bonner; Sue A Brown Journal: J Diabetes Sci Technol Date: 2021-01-15
Authors: Satish K Garg; Stuart A Weinzimer; William V Tamborlane; Bruce A Buckingham; Bruce W Bode; Timothy S Bailey; Ronald L Brazg; Jacob Ilany; Robert H Slover; Stacey M Anderson; Richard M Bergenstal; Benyamin Grosman; Anirban Roy; Toni L Cordero; John Shin; Scott W Lee; Francine R Kaufman Journal: Diabetes Technol Ther Date: 2017-01-30 Impact factor: 6.118
Authors: Tadej Battelino; Thomas Danne; Richard M Bergenstal; Stephanie A Amiel; Roy Beck; Torben Biester; Emanuele Bosi; Bruce A Buckingham; William T Cefalu; Kelly L Close; Claudio Cobelli; Eyal Dassau; J Hans DeVries; Kim C Donaghue; Klemen Dovc; Francis J Doyle; Satish Garg; George Grunberger; Simon Heller; Lutz Heinemann; Irl B Hirsch; Roman Hovorka; Weiping Jia; Olga Kordonouri; Boris Kovatchev; Aaron Kowalski; Lori Laffel; Brian Levine; Alexander Mayorov; Chantal Mathieu; Helen R Murphy; Revital Nimri; Kirsten Nørgaard; Christopher G Parkin; Eric Renard; David Rodbard; Banshi Saboo; Desmond Schatz; Keaton Stoner; Tatsuiko Urakami; Stuart A Weinzimer; Moshe Phillip Journal: Diabetes Care Date: 2019-06-08 Impact factor: 19.112
Authors: Elvira Isganaitis; Dan Raghinaru; Louise Ambler-Osborn; Jordan E Pinsker; Bruce A Buckingham; R Paul Wadwa; Laya Ekhlaspour; Yogish C Kudva; Carol J Levy; Gregory P Forlenza; Roy W Beck; Craig Kollman; John W Lum; Sue A Brown; Lori M Laffel Journal: Diabetes Technol Ther Date: 2021-01-21 Impact factor: 6.118
Authors: Thomas Danne; Revital Nimri; Tadej Battelino; Richard M Bergenstal; Kelly L Close; J Hans DeVries; Satish Garg; Lutz Heinemann; Irl Hirsch; Stephanie A Amiel; Roy Beck; Emanuele Bosi; Bruce Buckingham; Claudio Cobelli; Eyal Dassau; Francis J Doyle; Simon Heller; Roman Hovorka; Weiping Jia; Tim Jones; Olga Kordonouri; Boris Kovatchev; Aaron Kowalski; Lori Laffel; David Maahs; Helen R Murphy; Kirsten Nørgaard; Christopher G Parkin; Eric Renard; Banshi Saboo; Mauro Scharf; William V Tamborlane; Stuart A Weinzimer; Moshe Phillip Journal: Diabetes Care Date: 2017-12 Impact factor: 19.112
Authors: Kellee M Miller; Lauren G Kanapka; Michael R Rickels; Andrew J Ahmann; Grazia Aleppo; Lynn Ang; Anuj Bhargava; Bruce W Bode; Anders Carlson; Naomi S Chaytor; Gail Gannon; Robin Goland; Irl B Hirsch; Lisa Kiblinger; Davida Kruger; Yogish C Kudva; Carol J Levy; Janet B McGill; Grenye O'Malley; Anne L Peters; Louis H Philipson; Athena Philis-Tsimikas; Rodica Pop-Busui; Maamoun Salam; Viral N Shah; Michael J Thompson; Francesco Vendrame; Alandra Verdejo; Ruth S Weinstock; Laura Young; Richard Pratley Journal: Diabetes Technol Ther Date: 2022-04-11 Impact factor: 7.337
Authors: Charlotte K Boughton; Sara Hartnell; Hood Thabit; Womba M Mubita; Katharine Draxlbauer; Tina Poettler; Malgorzata E Wilinska; Korey K Hood; Julia K Mader; Parth Narendran; Lalantha Leelarathna; Mark L Evans; Roman Hovorka Journal: Lancet Healthy Longev Date: 2022-03-07
Authors: Jennifer L Sherr; Lutz Heinemann; G Alexander Fleming; Richard M Bergenstal; Daniela Bruttomesso; Hélène Hanaire; Reinhard W Holl; John R Petrie; Anne L Peters; Mark Evans Journal: Diabetologia Date: 2022-10-06 Impact factor: 10.460